142 related articles for article (PubMed ID: 33399309)
1. Factors Associated With and Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial Participants.
Henry RT; Jiamsakul A; Law M; Losso M; Kamarulzaman A; Phanuphak P; Kumarasamy N; Foulkes S; Mohapi L; Nwizu C; Wood R; Kelleher A; Polizzotto M;
J Acquir Immune Defic Syndr; 2021 May; 87(1):720-729. PubMed ID: 33399309
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.
Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N
J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524
[TBL] [Abstract][Full Text] [Related]
3. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
Fenner L; Atkinson A; Boulle A; Fox MP; Prozesky H; Zürcher K; Ballif M; Furrer H; Zwahlen M; Davies MA; Egger M;
J Int AIDS Soc; 2017 Jun; 20(1):21327. PubMed ID: 28691438
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort study.
Akanbi MO; Achenbach CJ; Feinglass J; Taiwo B; Onu A; Pho MT; Agbaji O; Kanki P; Murphy RL
AIDS Res Hum Retroviruses; 2013 Jun; 29(6):931-7. PubMed ID: 23316724
[TBL] [Abstract][Full Text] [Related]
5. Incidence of active tuberculosis among people living with HIV receiving long-term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy.
Suwanpimolkul G; Gatechompol S; Kawkitinarong K; Ueaphongsukkit T; Sophonphan J; Siriyakorn N; Jirajariyavej S; Khusuwan S; Panarat P; Wannalerdsakun S; Saetiew N; Chayangsu S; Wiwatrojanagul S; Noopetch P; Danpornprasert P; Mekviwattanawong S; Fujitnirun C; Lertpiriyasuwat C; Han WM; Kerr SJ; Ruxrungtham K; Avihingsanon A;
J Int AIDS Soc; 2022 Apr; 25(4):e25900. PubMed ID: 35384317
[TBL] [Abstract][Full Text] [Related]
6. Incidence of tuberculosis and the need of prophylactic treatment in persons living with HIV in Stockholm during the era of anti-retroviral therapy 1996-2013.
Norrby M; Wannheden C; Ekström AM; Berggren I; Lindquist L
Infect Dis (Lond); 2018; 50(11-12):807-816. PubMed ID: 30362392
[TBL] [Abstract][Full Text] [Related]
7. The tuberculosis challenge in a rural South African HIV programme.
Houlihan CF; Mutevedzi PC; Lessells RJ; Cooke GS; Tanser FC; Newell ML
BMC Infect Dis; 2010 Feb; 10():23. PubMed ID: 20146818
[TBL] [Abstract][Full Text] [Related]
8. Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.
Karo B; Krause G; Castell S; Kollan C; Hamouda O; Haas W;
BMC Infect Dis; 2017 Jul; 17(1):517. PubMed ID: 28743248
[TBL] [Abstract][Full Text] [Related]
9. A Clinical Algorithm to Identify HIV Patients at High Risk for Incident Active Tuberculosis: A Prospective 5-Year Cohort Study.
Lee SS; Lin HH; Tsai HC; Su IJ; Yang CH; Sun HY; Hung CC; Sy CL; Wu KS; Chen JK; Chen YS; Fang CT
PLoS One; 2015; 10(8):e0135801. PubMed ID: 26280669
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
[TBL] [Abstract][Full Text] [Related]
11. Incidence and factors associated with active tuberculosis among people living with HIV after long-term antiretroviral therapy in Thailand: a competing risk model.
Gatechompol S; Sophonphan J; Ubolyam S; Avihingsanon A; van Leth F; Cobelens F; Kerr SJ
BMC Infect Dis; 2022 Apr; 22(1):346. PubMed ID: 35387594
[TBL] [Abstract][Full Text] [Related]
12. The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study.
Assefa A; Gelaw B; Getnet G; Yitayew G
BMC Infect Dis; 2014 Aug; 14():468. PubMed ID: 25164855
[TBL] [Abstract][Full Text] [Related]
13. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
Shoko C; Chikobvu D; Bessong PO
S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
[TBL] [Abstract][Full Text] [Related]
14. Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.
Ndiaye BP; Thienemann F; Ota M; Landry BS; Camara M; Dièye S; Dieye TN; Esmail H; Goliath R; Huygen K; January V; Ndiaye I; Oni T; Raine M; Romano M; Satti I; Sutton S; Thiam A; Wilkinson KA; Mboup S; Wilkinson RJ; McShane H;
Lancet Respir Med; 2015 Mar; 3(3):190-200. PubMed ID: 25726088
[TBL] [Abstract][Full Text] [Related]
15. Improving survival with tuberculosis & HIV treatment integration: A mini-review.
Naidoo K; Rampersad S; Karim SA
Indian J Med Res; 2019 Aug; 150(2):131-138. PubMed ID: 31670268
[TBL] [Abstract][Full Text] [Related]
16. Viral Load and CD4
Widiyanti M; Adiningsih S; Kridaningsih TN; Fitrianingtyas R
Asia Pac J Public Health; 2023 Nov; 35(8):510-515. PubMed ID: 37727963
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.
Van Rie A; Westreich D; Sanne I
J Acquir Immune Defic Syndr; 2011 Apr; 56(4):349-55. PubMed ID: 20926954
[TBL] [Abstract][Full Text] [Related]
18. The incidence of tuberculosis among hiv-positive individuals with high CD4 counts: implications for policy.
Kufa T; Chihota V; Mngomezulu V; Charalambous S; Verver S; Churchyard G; Borgdorff M
BMC Infect Dis; 2016 Jun; 16():266. PubMed ID: 27286814
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis infection and disease in South African adolescents with perinatally acquired HIV on antiretroviral therapy: a cohort study.
Frigati LJ; Wilkinson KA; le Roux S; Brown K; Ruzive S; Githinji L; Petersen W; Belard S; Cotton MF; Myer L; Zar HJ
J Int AIDS Soc; 2021 Mar; 24(3):e25671. PubMed ID: 33719199
[TBL] [Abstract][Full Text] [Related]
20. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
